Not Signed In - Pharmasset Initiates Multiple Ascending Dose Study Of R7128 In Patients Chronically Infected With HCV Genotype 1
Thu, 01 Mar 2007 08:00 AM EST
... Pharmasset initiated the multiple ascending dose portion of an on-going Phase 1 clinical trial evaluating R7128 in up to 40 patients chronically infected with hepatitis C virus (HCV) genotype 1. [click link for full article] ...
Related Topics
- Ribavirin Tablets
- Multiple Myeloma
- Myeloma, Multiple
- Myeloma
- Naltrexone
- Peginterferon alfa-2a
- Multiple Chemical Sensitivity
- Infantile-onset ascending hereditary spastic paralysis
- Methylprednisolone
- Twins, Triplets, Multiple Births
- Multiple System Atrophy
- Viral Load
- Recessive multiple epiphyseal dysplasia
- Seizures (in about half of patients)
- What Your Female Patients Want to Know About Bladder Control
- Vaccinations For HIV/AIDs Patients
- Smoking Cessation and Continued Risk in Cancer Patients
- Fluid collections in the pancreas (pancreatic pseudocysts) that may become infected
- Multiple Sclerosis/ms
- Blood clots or an infected clot that travels other organs, causing infection and severe damage
email this page
print this page
bookmark this page
feedback on this page
